All materials were obtained from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. Immortal human RPE cells (ARPE-19; ATCC, Manassas, VA) were seeded from ATCC’s stock and grown as described by Dunn et al.
32 The cells were grown in filter (0.1 μm)-sterilized basal growth medium DMEM/F12 (Invitrogen, CA) supplemented with 10% fetal bovine serum (Invitrogen), 1% (vol/vol) 200 mM
l-glutamine (Invitrogen), 0.2% (vol/vol) 50 mg/mL gentamicin (Invitrogen), normicin (Invivogen, San Diego, CA), 1% of 10,000 units/10,000 μg penicillin/streptomycin (Invitrogen), and 3.7 g/L cell culture grade NaHCO
3. The complete medium was filter (0.2 μm) sterilized a second time before inoculation. Cells were grown at 37°C with 10% CO
2 atmosphere, and the medium was changed every 5 to 7 days. Cells were subcultured from near-confluent to confluent cultures after release with trypsin (0.05%)-EDTA (1 mM) in Hanks’ balanced salt solution (HBSS) without Ca
2+ or Mg
2+ (Invitrogen). Total cell passage did not exceed 30 times.